ZHONGSHAN, China - s4story -- Transtek recently hosted a successful roundtable in Yunnan under the theme "Prevention, Interruption, and Reversal of Heart Disease," bringing together renowned international experts and healthcare innovators to explore the future of cardiovascular care.

Among the distinguished participants were Prof. Barry A. Franklin, a key figure in the American Society for Preventive Cardiology, and Dr. Weimo Zhu, a Fellow of the American College of Sports Medicine. Together with other leading experts, they engaged in in-depth discussions on evidence-based strategies aimed at preventing and managing heart disease—one of the world's leading causes of death. Topics included the importance of early detection, lifestyle intervention, and the role of exercise in long-term heart health.

A highlight of the event was the presentation by Dr. Ziyi Liu, Director of R&D at Transtek. He introduced Transtek's cutting-edge chronic disease management AI model, which leverages continuous health data collected from remote smart devices. By analyzing this data, the model generates personalized cardiovascular risk profiles and intervention recommendations, offering a more proactive and precise approach to heart health management.

More on S For Story

• NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
• Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
• Do You Know Why Nobody Sits Like the French?
• ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
• Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa

This roundtable not only underscored the growing importance of digital health solutions in chronic disease care but also reflected Transtek's deep commitment to innovation and public health. By bridging clinical expertise with advanced technology, Transtek continues to empower healthcare professionals and patients alike in the global fight against cardiovascular disease.

Founded in 2000, Transtek is committed to multiple health fields such as remote health and chronic disease management, providing customers with medical-grade "RPM devices" and "cloud services". Transtek also provides one-stop connectivity technology, device management, and fulfillment services for Remote Patient Monitoring (RPM) providers. Transtek has established a co-branded solution named TeleRPM since 2019, it stands for Quality & Value which is the best of Transtek. TeleRPM is an integrated solution which includes cellular blood pressure monitor, cellular weight scale, cellular blood glucose meter and all-round BLE package with AnyHub solution. Also, TeleRPM is open and scalable, and Transtek will leverage their expertise to help customers realize greater value, potential and outcomes.